Patent Assignment
Reel/Frame 059401/0943
Assignment of Assignor's Interest
Recorded: 2022-03-25
Pages: 9
Assignors
ECKELMAN, BRENDAN P.
Executed: 2016-03-31
TIMMER, JOHN C.
Executed: 2016-03-08
DEVERAUX, QUINN
Executed: 2016-03-08
Assignee
INHIBRX LP
11099 NORTH TORREY PINES ROAD, SUITE 280, LA JOLLA, CALIFORNIA, 92037
Covered Property
(1)
Non-Immunogenic Single Domain Antibodies
Application:
16/685,087 →
Publication:
US 2020/0140525
Related Assignments
(5)
Other recorded transfers of the patent in this record — the chain of ownership.
Intellectual Property Security Agreement
Feb 28, 2022
From: INHIBRX, INC.
To: OXFORD FINANCE LLC
Reel/Frame 059262/0780 →
Merger and Change of Name
Mar 25, 2022
From: INHIBRX LP; TENIUM THERAPEUTICS, INC.
To: INHIBRX, INC.
Reel/Frame 059501/0951 →
Assignment of Assignor's Interest
Mar 25, 2022
From: INHIBRX BIOPHARMA, LLC
To: INHIBRX LP
Reel/Frame 059401/0954 →
Release of Security Interest
Jun 3, 2024
From: OXFORD FINANCE LLC, AS COLLATERAL AGENT
To: INHIBRX, INC.
Reel/Frame 067606/0247 →
Assignment of Assignor's Interest
Jun 10, 2024
From: INHIBRX, INC.
To: INHIBRX BIOSCIENCES, INC.
Reel/Frame 067680/0770 →